Viewing nowCombinationTwinheart Tablets 40/10 mg
Telmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 201702117 · Approved 2017.04.26 · Insurance code 657307050
Treatment of essential hypertension not controlled with monotherapy
This medication helps effectively lower blood pressure in patients with essential hypertension who are not sufficiently controlled with monotherapy using amlodipine or telmisartan. It stabilizes blood pressure, reducing the risk of cardiovascular diseases. The combination therapy of both medications complements each other’s effects, making it effective for blood pressure management. It is used for the treatment of essential hypertension and improves blood pressure control according to the patient's condition.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take the medicine at the same time each day (e.g., in the morning). It is recommended that the doses of the individual components (amlodipine or telmisartan) be adjusted before administering this medicine. However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients who should be administered the medicine with caution’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, administration of this medicine is not recommended.
This medication can pose a serious risk to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. Additionally, individuals allergic to any of the components of this medication, nursing women, and patients with severe liver disease or heart-related issues should not take this medication. Special caution is required when using this medication in patients with primary aldosteronism or certain heart valve diseases, and those with poor liver function. Patients with gastrointestinal diseases or kidney function problems should also be cautious when taking this medication. Possible side effects may include dizziness, swelling, decreased blood pressure, and more severe adverse reactions may occur rarely. Patients should be particularly cautious if blood pressure drops too low or if they have diminished heart function, and should consult a healthcare professional immediately if severe side effects occur. This medication may interact with other drugs, so inform healthcare providers about any other medications being taken. If pregnant or breastfeeding, it is essential to stop taking this medication and seek alternative treatment options. Older adults may need dosage adjustments, thus following medical advice is recommended. Overdose may lead to hypotension, dizziness, and cardiac issues, requiring immediate emergency treatment. This medication is not recommended for children as safety and efficacy have not been sufficiently established.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that protects it from light. It is best stored at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer time.
Biconvex oval double tablet with one side white and the other side pale blue
30 tablets/box [10 tablets/Alu-Alu X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.